Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 86Neoplasm Metastasis 75Colorectal Neoplasms 74Neoplasms 70Leukemia, Myeloid, Acute 61Breast Neoplasms 57Multiple Myeloma 48Prostatic Neoplasms 47Ovarian Neoplasms 44Squamous Cell Carcinoma of Head and Neck 39Pancreatic Neoplasms 39Melanoma 36Recurrence 34Triple Negative Breast Neoplasms 31Lymphoma, Non-Hodgkin 31Lung Neoplasms 31Glioblastoma 30Myelodysplastic Syndromes 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Endometrial Neoplasms 27Advanced Solid Tumors 27Stomach Neoplasms 25Carcinoma, Renal Cell 25Small Cell Lung Carcinoma 24Sarcoma 23Carcinoma, Hepatocellular 21Brain Neoplasms 21Lymphoma, Large B-Cell, Diffuse 19Esophageal Neoplasms 19Lymphoma, B-Cell 17

Interventions

pembrolizumab 1Fluorouracil 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Malignant Solid Tumor × 30 days × Clear all
NCT06057038 2026-06-02

A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors

Genmab

Phase 1 Active not recruiting
42 enrolled
Other solid neoplasm

Malignant Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡